-
December 9: The Week in Cancer News
Medical marijuana used as a substitute for opioids, and chemo and endocrine therapy together increase cancer-related cognitive impairment.
by Kevin McLaughlin
-
December 2: The Week in Cancer News
Oncologists report that prior authorization process interrupts cancer care, and plant-based diet is associated with lower colorectal cancer risk in men but not women.
by Eric Fitzsimmons
-
November 18: The Week in Cancer News
Vaccine helps people with brain cancer live longer, and kidney cancer patients see results from off-the-shelf CAR T-cell therapy.
by Thomas Celona
-
November 11: The Week in Cancer News
California passes ballot initiative banning flavored tobacco products, and the FDA approves combination treatments for lung cancer.
by Kevin McLaughlin
-
November 4: The Week in Cancer News
Female patients less likely than men to be told about sexual side effects of treatment, and independent analysis finds cancer-causing chemical in dry shampoo.
by Marci A. Landsmann
-
October 28: The Week in Cancer News
Clinical trial finds select breast cancer patients can forgo surgery, and cancer organizations warn of growing e-cigarette use among teens.
by Thomas Celona
-
October 21: The Week in Cancer News
Chemical hair straightening is associated with higher uterine cancer risk, and gas stoves can leak chemicals linked to cancer.
by Eric Fitzsimmons
-
October 14: The Week in Cancer News
Colonoscopy study results are misreported, and progress is seen in cancer vaccines.
by Kevin McLaughlin
-
October 7: The Week in Cancer News
Transportation barriers increase risk of death for people with cancer, and new rules go into effect to give patients full access to medical records.
by Marci A. Landsmann
-
September 30: The Week in Cancer News
Firefighters face increased cancer risk due to exposure to ‘forever chemicals,’ and cancer-related fatigue can put breast cancer survivors at risk for falls.
by Thomas Celona
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore